Literature DB >> 27373852

Activation of PPAR-γ inhibits PDGF-induced proliferation of mouse renal fibroblasts.

Jiamei Lu1, Jianhua Shi2, Baosong Gui1, Ganglian Yao1, Li Wang1, Yan Ou1, Dan Zhu1, Liqun Ma1, Heng Ge1, Rongguo Fu3.   

Abstract

Recent studies have shown that activation of peroxisome proliferators activated receptor-γ (PPAR-γ) ameliorates renal interstitial fibrosis (RIF) in animal model. Yet, the underlying molecular mechanisms remain still largely unknown. Here, we investigated the hypothesis that activation of PPAR-γ regulates renal remodeling by modulating proliferation of primary cultured renal fibroblasts. In our present study, platelet-derived growth factor-AA (PDGF-AA), a key isoform of PDGF superfamily as mitogen in RIF, was applied to stimulate renal fibroblasts, the selective inhibitor or sequence specific siRNA of PI3K, skp2 or PPAR-γ was used to investigate the involvement of above molecular mediators in PDGF-AA-induced cell proliferation. Our results demonstrate that PDGF-AA induced proliferation of renal fibroblasts by activating PI3K/AKT signaling and resultant skp2 production. Pre-stimulation of cells with rosiglitazone or adenovirus carrying PPAR-γ cDNA (AdPPAR-γ) blocked PDGF-AA-stimulated cell proliferation, this effect was particularly coupled to PPAR-γ inhibition of AKT phosphorylation and skp2 expression. Inhibition of PPAR-γ by GW9662 restored the suppression of activated PPAR-γ on phosphorylation of AKT and subsequent skp2 production. Our results indicate that activation of PI3K/AKT signaling and resultant skp2 generation mediated PDGF-induced proliferation of renal fibroblasts. Activation of PPAR-γ inhibited cell proliferation by inhibition of AKT phosphorylation and its down-streams.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Peroxisome proliferators activated receptor-γ (PPAR-γ); Platelet-derived growth factor (PDGF); Proliferation; S-phase kinase associated protein-2 (Skp2)

Mesh:

Substances:

Year:  2016        PMID: 27373852     DOI: 10.1016/j.ejphar.2016.06.051

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Acute kidney injury leading to CKD is associated with a persistence of metabolic dysfunction and hypertriglyceridemia.

Authors:  Azadeh Harzandi; Sunjae Lee; Gholamreza Bidkhori; Sujit Saha; Bruce M Hendry; Adil Mardinoglu; Saeed Shoaie; Claire C Sharpe
Journal:  iScience       Date:  2021-01-09

Review 2.  The Role of Peroxisome Proliferator-Activated Receptors in Kidney Diseases.

Authors:  Jianjun Gao; Zhaoyan Gu
Journal:  Front Pharmacol       Date:  2022-03-04       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.